Watch for Children Who Are at Risk for Hepatitis B.(Brief Article)TUCKER, MIRIAM E
6. Hofmann E, Surial B, Boillat-Blanco N, Günthard HF, Stöckle M, Bernasconi E et al. Hepatitis B virus (HBV) replication during tenofovir therapy is frequent in human immunodeficiency virus/HBV coinfection. Clin Infect Dis. 2023;76:730–3. doi: 10.1093/cid/ciac823. 7. Liaw YF, ...
17. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen B et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71:539–48. doi: 10.1002/hep.30857. 18. Kim MA, Han K, Yoo J, Hwang S...
Third-partymaterials.Ifyouwishtoreusematerialfromthisworkthatisattributedtoathirdparty,suchastables, figuresorimages,itisyourresponsibilitytodeterminewhetherpermissionisneededforthatreuseandtoobtain permissionfromthecopyrightholder.Theriskofclaimsresultingfrominfringementofanythird-party-owned componentintheworkrestssole...
(t)ide analog-treated patients in an area where HBV/B is more prevalent than in other areas of Japan.A total of 498 chronically HBV-infected patients treated with nucleos(t)ide analog (lamivudine, entecavir, tenofovir disoproxil fumarate, or tenofovir alafenamide fumarate) for >6months (mean ...
Background: Hepatitis B vaccination (HepB) has been recommended for men who have sex with men (MSM) since 1982; coverage, however, remains low. Methods: We used the 2008 National HIV Behavioral Surveillance (NHBS) System to determine self-reported HepB coverage (≥1 dose) and missed opportu...
10. Schwartz SS, Epstein S, Corkey BE,Grant SF, Gavin JR 3rd, Aguilar RB. The time is right for a newclassification system for diabetes: rationale and implications of theβ-cell-centric classification schema. Diabetes Care. 2016;39:179–86. ...
10. Schwartz SS, Epstein S, Corkey BE,Grant SF, Gavin JR 3rd, Aguilar RB. The time is right for a newclassification system for diabetes: rationale and implications of theβ-cell-centric classification schema. Diabetes Care. 2016;39:179–86. ...
We conclude that although this retrospective procedure is time-consuming and difficult, substantial numbers of infected recipients can be identified. The availability of treatment for chronic hepatitis C for such patients should encourage transfusion services to reassess current policies on the hepatitis C...
BACKGROUND: Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population size for hepatitis C virus (HCV) and hepatitis B ...